| 000 | 01388 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511193515.0 | ||
| 264 | 0 | _c19920702 | |
| 008 | 199207s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1177/106002809202600505 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKing, J H | |
| 245 | 0 | 0 |
_aSuccessful use of higher-than-recommended dosage of imipenem in Pseudomonas aeruginosa endocarditis. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cMay 1992 |
||
| 300 |
_a639-41 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCilastatin _xadministration & dosage |
| 650 | 0 | 4 | _aCilastatin, Imipenem Drug Combination |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadministration & dosage |
| 650 | 0 | 4 |
_aEndocarditis, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImipenem _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
| 700 | 1 | _aKailath, E J | |
| 700 | 1 | _aHrdy, D B | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 26 _gno. 5 _gp. 639-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002809202600505 _zAvailable from publisher's website |
| 999 |
_c1597903 _d1597903 |
||